| Financial Year |
March 31 2023 |
| Monetary Funds |
677,044,422.53 |
| Held-for-trading Financial Assets |
651,225,024.88 |
| Notes Receivable |
-- |
| Accounts Receivable |
407,006,822.74 |
| Advances to Suppliers |
23,881,746.98 |
| Other Receivables |
13,202,989.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
521,843,733.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
130,705,135.62 |
| Total Current Assets |
2,424,909,875.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
27,290,639.88 |
| Investment Properties |
-- |
| Fixed Assetes |
585,619,887.98 |
| Under-construction Projects |
351,410,982.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
101,247,575.38 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,248,861.81 |
| Deferred Income Tax Assets |
39,893,047.07 |
| Other Non-Current Assets |
23,646,784.15 |
| Sub-Total of Non-Current Assets |
1,262,737,234.88 |
| Total Assets |
3,687,647,109.90 |
| Short-Term Loans |
398,383,218.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
697,820,682.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,715,979.85 |
| Taxes Payable |
18,903,064.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,720,476.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,120,590.20 |
| Sub-Total of Current Liabilities |
1,181,913,752.93 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,575,993.84 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
36,532,865.29 |
| Total Liabilities |
1,218,446,618.22 |
| Paid-In Capital(Or Share Stock) |
338,388,800.00 |
| Capital Surplus |
1,602,314,259.26 |
| Surplus Reserve |
43,703,773.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
471,394,426.67 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,469,200,491.68 |
| Owner's Equity（Stockholder's Equity） |
2,469,200,491.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,687,647,109.90 |
